Outpatient Facility Coding Alert - 2021 Issue 1
COVID-19: Get the Facts on Part B Payment Rates for Future Vaccines
Subscribe or sign in to view the full article.
Article Overview
This article reviews CMS guidance tied to a COVID-19 interim final rule and explains how the rule affects vaccine access, Medicare Part B payment policy, private health plan coverage, inpatient and outpatient payment approaches, and diagnostic test pricing transparency. It is relevant to coders, billers, compliance staff, and revenue cycle teams following federal COVID-19 payment and coverage changes.
Why This Topic Matters
The rule addresses fast-changing pandemic policy that affects coverage, reimbursement, and provider obligations across multiple payment settings. Understanding the scope of these updates helps organizations stay aligned with Medicare, private payer, and transparency requirements.
Article Sections
-
Overview of CMS COVID-19 interim final rule
Introduces the federal rulemaking context and the broader set of coronavirus-related policy updates addressed by CMS.
-
Private payer coverage changes
Summarizes coverage-related updates for certain health plans under CARES Act-related requirements and preventive service policy.
-
Vaccine payment rates
Covers Medicare Part B payment policy for vaccine administration and general payment methodology updates tied to COVID-19 vaccines.
-
IPPS inpatient payment update
Describes the inpatient payment changes for eligible cases involving newer COVID-19 treatments under the hospital prospective payment system.
-
OPPS outpatient payment update
Summarizes outpatient payment changes for new COVID-19 treatments furnished in connection with certain outpatient services during the public health emergency.
-
Testing price transparency requirements
Explains the rule’s additions related to disclosure of COVID-19 diagnostic test pricing and related provider obligations.
What You Will Learn
- How CMS’s COVID-19 interim final rule affects coverage and payment policy
- What categories of Medicare and private payer changes are addressed
- Which areas of hospital and outpatient payment policy are updated
- How the rule relates to diagnostic test price transparency requirements
- What compliance-focused topics are discussed in the article
Who Should Read This
- Medical coders
- Medical billers
- Compliance professionals
- Revenue cycle staff
- Healthcare administrators
- Health plan staff
Subscribe or sign in to view the full article.


Quick, Current, Complete - www.findacode.com